(Q46988894)

27 December 2017

title

The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine (English)

1 reference

27 December 2017

author name string

Sugai T

1

1 reference

27 December 2017

Suzuki Y

2

1 reference

27 December 2017

Sawamura K

3

1 reference

27 December 2017

Fukui N

4

1 reference

27 December 2017

Inoue Y

5

1 reference

27 December 2017

Someya T

6

1 reference

27 December 2017

publication date

14 March 2006

1 reference

27 December 2017

The Pharmacogenomics Journal

published in

1 reference

27 December 2017

volume

6

1 reference

27 December 2017

issue

5

1 reference

27 December 2017

page(s)

351-356

1 reference

27 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.tpj.6500382

exact match

0 references

cites work

Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Analysis of 5-HT3 receptor antagonist, ramosetron hydrochloride, based on receptor occupancy considering its active metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Association between the 5' UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Investigation of the association between 5-HT3A receptor gene polymorphisms and efficiency of antiemetic treatment with 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Comparative efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

Differential composition of 5-hydroxytryptamine3 receptors synthesized in the rat CNS and peripheral nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

7 January 2021

Cancer therapy, vomiting, and antiemetics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

7 January 2021

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

7 January 2021

A novel deletion of the l-ferritin iron-responsive element responsible for severe hereditary hyperferritinaemia-cataract syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

7 January 2021

The relationship between paroxetine and the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500382

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500382

1 reference

27 December 2017

1 reference

27 December 2017